Tech Company Financing Transactions
Caribou Biosciences Funding Round
Caribou Biosciences, based in Berkeley, scored $11 million in funding from F-Prime Capital, private investors and Mission Bay Capital.
Transaction Overview
Company Name
Announced On
4/3/2015
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
F-Prime Capital (Robert Weisskoff)
private investors (Jennifer Doudna)
Proceeds Purpose
This funding will allow us to further accelerate deployment of our advanced genome editing platform.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2929 7th St. 105
Berkeley, CA 94710
USA
Berkeley, CA 94710
USA
Phone
Website
Email Address
Overview
Caribou is a developer of cellular engineering and analysis solutions based on CRISPR technologies. Caribou's tools and technologies provide transformative capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and basic and applied biological research.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rachel Haurwitz
Chief Financial Officer
Jason O'Byrne
Chief Scientific Officer
Steven Kanner
Vice President
Chris Fuller
Vice President
Justin Skoble
Vice President
Cherry Thomas
VP - Finance
Ryan Fischesser
VP - General Counsel
Barbara McClung
VP - Human Resources
Cindy Hayashi
VP - R & D
Scott Gradia
VP - Regulatory Affairs
Elaine Alambra
Browse more venture capital transactions:
Prev: 4/3/2015: Huckle venture capital transaction
Next: 4/3/2015: MX Orthopedics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs